Meperidine (Pethidine): Avoid Use in Most Clinical Scenarios
Meperidine should generally not be used in older adults, and its use is not recommended in patients with renal impairment (GFR <30 mL/min/1.73 m²) due to accumulation of the toxic metabolite normeperidine, which causes CNS excitation including seizures, tremors, and hallucinations. 1, 2, 3
Key Contraindications and High-Risk Populations
Absolute Avoidance Recommended:
- Renal impairment (GFR <30 mL/min/1.73 m²): Normeperidine accumulates and cannot be adequately cleared, leading to neurotoxicity 2, 3, 4
- Elderly patients: Consensus guidelines specifically identify meperidine as having the highest agreement among experts that it should not be used in older adults below specified renal function thresholds 1
- Hepatic impairment: Both meperidine and normeperidine accumulate 3
Relative Contraindications:
- Patients receiving serotonergic or noradrenergic medications (increased toxicity risk) 2
- Pheochromocytoma (can provoke hypertension) 3
- Concomitant use with ritonavir (increases normeperidine levels—avoid combination) 3
Dosing Guidelines (When Absolutely Necessary)
Standard Adult Dosing:
- Oral: 50-150 mg every 3-4 hours as needed 3
- Maximum safe dose: ≤10 mg/kg/day for no longer than 3 days 5
- Doses >10 mg/kg/day significantly increase risk of CNS toxicity 5
Pediatric Dosing:
- 1.1-1.8 mg/kg orally every 3-4 hours (up to adult dose) 3
- Safety and effectiveness not established in pediatric patients 3
Elderly Patients:
- Reduce total daily dose by 25-50% 3
- Elderly have slower elimination and increased susceptibility to effects 3, 6
- Volume of distribution increases significantly with age (300% increase in initial volume) 6
Renal Impairment:
- GFR <30 mL/min: Avoid entirely 2, 3
- Even with hemodialysis, normeperidine accumulates between sessions despite 65% removal during dialysis 7
Critical Drug Interactions
Dose reduction of 25-50% required when combined with:
- Phenothiazines and tranquilizers (potentiate meperidine effects) 3
Exercise caution or avoid:
- Acyclovir: Increases meperidine and normeperidine concentrations 3
- Cimetidine: Reduces clearance and increases normeperidine 3
- Phenytoin: Increases normeperidine levels despite reducing parent drug 3
- CNS depressants: Risk of respiratory depression, profound sedation, coma, or death 3
Adverse Drug Reaction Profile
CNS toxicity from normeperidine accumulation includes:
- Confusion, anxiety, nervousness
- Hallucinations
- Tremors and myoclonic jerking
- Seizures
Incidence: 14% of patients experienced ADRs in one institutional review, with 2% developing frank CNS toxic reactions 5, 8
High-risk scenarios for ADRs:
- Patient-controlled analgesia (PCA) use (16 of 20 ADR cases involved PCA) 8
- Cumulative doses >863 mg (median dose in ADR group vs 455 mg in non-ADR group) 8
- Concomitant benzodiazepine use (65% of ADR patients vs 4.1% without ADRs) 8
- Older age (mean 58.5 vs 46.4 years) 8
Clinical Pitfalls to Avoid
Duration trap: Even short-term use (3 days) at high doses can cause toxicity—do not exceed this timeframe 5
PCA overuse: Patients using PCA are at particularly high risk due to cumulative dosing patterns 8
Renal function monitoring: Daily patient evaluation is mandatory; even mild renal dysfunction increases risk 5
Metabolite accumulation: Unlike parent drug, normeperidine has a half-life of 15-30 hours and accumulates with repeated dosing 9, 4
False reassurance from normal morphine tolerance: Patients may tolerate morphine well but still develop normeperidine toxicity 4
Preferred Alternatives
For patients with renal impairment, use opioids without active metabolites:
- Fentanyl
- Sufentanil
- Methadone (requires experienced prescriber) 2
Use with caution and dose adjustment in renal impairment:
- Hydrocodone
- Oxycodone
- Hydromorphone 2
The evidence strongly supports that meperidine has poor efficacy, multiple dangerous drug interactions, and unacceptable toxicity risk, particularly in vulnerable populations. The perioperative period should be used as an opportunity to optimize pain management strategy away from meperidine 2.